Tea tree oil
- Generic Name
- Tea tree oil
- Drug Type
- Biotech
- CAS Number
- 68647-73-4
- Unique Ingredient Identifier
- VIF565UC2G
Overview
Tea tree oil is an essential oil derived mainly from the Australian native plant Melaleuca alternifolia via steam distillation of the of the leaves and terminal branches . It may be referred to as Melaleuca alternifolia oil. It has been a popular ingredient in a variety of household and cosmetic products due to its antiseptic, anti-inflammatory, broad-spectrum antimicrobial and antioxidant properties . The dermatological use of tea tree oil has been investigated by various studies, where several studies have suggested the uses of this oil for the treatment of acne vulgaris, seborrheic dermatitis, and chronic gingivitis . Terpene hydrocarbons and related alcohols constitute tea tree oil, with Terpinen-4-ol being the major antimicrobial component .
Background
Tea tree oil is an essential oil derived mainly from the Australian native plant Melaleuca alternifolia via steam distillation of the of the leaves and terminal branches . It may be referred to as Melaleuca alternifolia oil. It has been a popular ingredient in a variety of household and cosmetic products due to its antiseptic, anti-inflammatory, broad-spectrum antimicrobial and antioxidant properties . The dermatological use of tea tree oil has been investigated by various studies, where several studies have suggested the uses of this oil for the treatment of acne vulgaris, seborrheic dermatitis, and chronic gingivitis . Terpene hydrocarbons and related alcohols constitute tea tree oil, with Terpinen-4-ol being the major antimicrobial component .
Indication
Indicated for topical use to help protect against infection in minor cuts, scrapes, and burns. No FDA-approved therapeutic indications.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/04/01 | Phase 4 | Completed | Altinbas University | ||
2023/04/07 | Not Applicable | Completed | |||
2010/02/23 | Phase 2 | Completed | Federal University of São Paulo |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|---|---|---|---|---|
TOPICAL | 0.006 mg in 30 mg | 2025/04/28 | 84983-008 | ||
TOPICAL | 42.5 mg in 1 g | 2015/02/16 | 69594-004 |
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|
No NMPA products found
No NMPA products found for this drug
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|---|---|---|---|---|
50205 | International Cosmetics Laboratories Pty Ltd | Active | 1994/08/29 | Melaleuca Oil | |
50165 | International Cosmetics Laboratories Pty Ltd | Active | 1994/08/25 | Melaleuca Oil | |
195769 | Active | 2012/03/15 | Melaleuca Oil | ||
311820 | Active | 2018/11/22 | Melaleuca Oil | ||
381950 | Active | 2022/01/06 | Melaleuca Oil | ||
484428 | Active | 2025/03/27 | Melaleuca Oil | ||
474236 | Active | 2024/12/20 | Melaleuca Oil | ||
200806 | Active | 2012/09/08 | Melaleuca Oil | ||
52613 | M H Nguyen | Active | 1995/05/25 | Melaleuca Oil | |
15674 | Active | 1991/09/12 | Melaleuca Oil |